
    
      Patients with a CTO, defined as 99% to 100% stenosis of a peripheral artery, will be
      approached for enrollment in the study. Following providing informed consent, the CTO will be
      addressed by the Wildcat catheter, which will provide a route for the advancement of
      guidewires and other tools beyond the CTO. Data will be collected to assess the safety
      efficacy of use of the device during the procedure and up to 30 days post-procedure.
    
  